A CRISPR method for genome engineering

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Wilkinson, Royce ^a   Wiedenheft, Blake ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRISPR ASSOCIATED PROTEIN; CRISPR ASSOCIATED PROTEIN 9; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARCHAEAL GENOME; BACTERIAL GENOME; BIOTECHNOLOGY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE CONTROL; GENETIC ENGINEERING; MICROBIAL GENOME; MOLECULAR RECOGNITION; NONHUMAN; REVIEW;

EID: 84891770491     PISSN: None     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-3     Document Type: Review

References (109)

1. Fineran PC, Charpentier E: Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new information. Virology 2012, 434:202-9.
2. Marraffini LA, Sontheimer EJ: CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nat Rev Genet 2010, 11:181-90.
3. Makarova KS, Haft DH, Barrangou R, Brouns SJJ, Charpentier E, Horvath P, Moineau S, Mojica FJM, Wolf YI, Yakunin AF, van der Oost J, Koonin EV: Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 2011, 9:467-77.
4. Sorek R, Lawrence CM, Wiedenheft B: CRISPR-mediated adaptive immune systems in bacteria and archaea. Annu Rev Biochem 2013, 82:237-66.
5. Wiedenheft B, Sternberg SH, Doudna JA: RNA-guided genetic silencing systems in bacteria and archaea. Nature 2012, 482:331-8.
6. Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA: Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res 2013, 41:7429-37.
7. Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA: RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat Biotechnol 2013, 31:233-9.
8. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA: Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013, 152:1173-83.
9. Esvelt KM, Mali P, Braff JL, Moosburner M, Yaung SJ, Church GM: Orthogonal Cas9 proteins for RNA-guided gene regulation and editing. Nat Methods 2013, 10:1116-21.
10. Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS: CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 2013, 154:442-51.
11. DiCarlo JE, Norville JE, Mali P, Rios X, Aach J, Church GM: Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 2013, 41:4336-43.
12. Cheng AW, Wang H, Yang H, Shi L, Katz Y, Theunissen TW, Rangarajan S, Shivalila CS, Dadon DB, Jaenisch R: Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res 2013, 23:1163-71.
13. Hou Z, Zhang Y, Propson NE, Howden SE, Chu L, Sontheimer EJ, Thomson JA: Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA 2013, 110:15644-9.
14. Ran FA, Hsu PD, Lin C, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F: Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013, 154:1380-9.
15. Cho SW, Kim S, Kim JM, Kim J: Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 2013, 31:230-2.
16. Le Cong, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F: Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-23.
17. Cradick TJ, Fine EJ, Antico CJ, Bao G: CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial offtarget activity. Nucleic Acids Res 2013, 41:9584-92.
18. Ding Q, Regan SN, Xia Y, Oostrom LA, Cowan CA, Musunuru K: Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 2013, 12:393-4.
19. Ebina H, Misawa N, Kanemura Y, Koyanagi Y: Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 2013, 3:2510.
20. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD: High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 2013, 31:822-6.
21. Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F: DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 2013, 31:827-32.
22. Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J: RNA-programmed genome editing in human cells. Elife 2013, 2:e00471.
23. Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH, Joung JK: CRISPR RNA-guided activation of endogenous human genes. Nat Methods 2013, 10:977-9.
24. Mali P, Aach J, Stranges PB, Esvelt KM, Moosburner M, Kosuri S, Yang L, Church GM: CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 2013, 31:833-8.
25. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM: RNA-guided human genome engineering via Cas9. Science 2013, 339:823-6.
26. Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR: Highthroughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat Biotechnol 2013, 31:839-43.
27. Perez-Pinera P, Kocak DD, Vockley CM, Adler AF, Kabadi AM, Polstein LR, Thakore PI, Glass KA, Ousterout DG, Leong KW, Guilak F, Crawford GE, Reddy TE, Gersbach CA: RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods 2013, 10:973-6.
28. Yang L, Guell M, Byrne S, Yang JL, Los Angeles A de, Mali P, Aach J, Kim-Kiselak C, Briggs AW, Rios X, Huang P, Daley G, Church G: Optimization of scarless human stem cell genome editing. Nucleic Acids Res 2013, 41:9049-61.
29. Bassett AR, Tibbit C, Ponting CP, Liu J: Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep 2013, 4:220-8.
30. Gratz SJ, Cummings AM, Nguyen JN, Hamm DC, Donohue LK, Harrison MM, Wildonger J, O'Connor-Giles KM: Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 2013, 194:1029-35.
31. Yu Z, Ren M, Wang Z, Zhang B, Rong YS, Jiao R, Gao G: Highly efficient genome modifications mediated by CRISPR/Cas9 in Drosophila. Genetics 2013, 195:289-91.
32. Kondo S, Ueda R: Highly improved gene targeting by germline-specific cas9 expression in Drosophila. Genetics 2013, 195:715-21.
33. Chang N, Sun C, Gao L, Zhu D, Xu X, Zhu X, Xiong J, Xi JJ: Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res 2013, 23:465-72.
34. Hwang WY, Fu Y, Reyon D, Maeder ML, Kaini P, Sander JD, Joung JK, Peterson RT, Yeh JJ: Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS ONE 2013, 8:e68708.
35. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, Peterson RT, Yeh JJ, Joung JK: Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 2013, 31:227-9.
36. Jao L, Wente SR, Chen W: Efficient multiplex biallelic zebrafish genome editing using a CRISPR nuclease system. Proc Natl Acad Sci USA 2013, 110:13904-9.
37. Xiao A, Wang Z, Hu Y, Wu Y, Luo Z, Yang Z, Zu Y, Li W, Huang P, Tong X, Zhu Z, Lin S, Zhang B: Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish. Nucleic Acids Res 2013, 41:e141.
38. Chen C, Fenk LA, Bono M de: Efficient genome editing in Caenorhabditis elegans by CRISPR-targeted homologous recombination. Nucleic Acids Res 2013, 41:e193.
39. Chiu H, Schwartz HT, Antoshechkin I, Sternberg PW: Transgene-Free Genome Editing in Caenorhabditis elegans Using CRISPR-Cas. Genetics 2013, 195:1167-71.
40. Cho SW, Lee J, Carroll D, Kim J, Lee J: Heritable Gene Knockout in Caenorhabditis elegans by Direct Injection of Cas9-sgRNA Ribonucleoproteins. Genetics 2013, 195:1177-80.
41. Friedland AE, Tzur YB, Esvelt KM, Colaiácovo MP, Church GM, Calarco JA: Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods 2013, 10:741-3.
42. Katic I, Großhans H: Targeted Heritable Mutation and Gene Conversion by Cas9-CRISPR in Caenorhabditis elegans. Genetics 2013, 195:1173-6.
43. Lo T, Pickle CS, Lin S, Ralston EJ, Gurling M, Schartner CM, Bian Q, Doudna JA, Meyer BJ: Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions. Genetics 2013, 195:331-48.
44. Tzur YB, Friedland AE, Nadarajan S, Church GM, Calarco JA, Colaiácovo MP: Heritable Custom Genomic Modifications in Caenorhabditis elegans via a CRISPR-Cas9 System. Genetics 2013, 195:1181-5.
45. Waaijers S, Portegijs V, Kerver J, Lemmens BBLG, Tijsterman M, van den Heuvel S, Boxem M: CRISPR/Cas9-Targeted Mutagenesis in Caenorhabditis elegans. Genetics 2013, 195:1187-91.
46. Dickinson DJ, Ward JD, Reiner DJ, Goldstein B: Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat Methods 2013, 10:1028-34.
47. Feng Z, Zhang B, Ding W, Liu X, Yang D, Wei P, Cao F, Zhu S, Zhang F, Mao Y, Zhu J: Efficient genome editing in plants using a CRISPR/Cas system. Cell Res 2013, 23:1229-32.
48. Li J, Norville JE, Aach J, McCormack M, Zhang D, Bush J, Church GM, Sheen J: Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nat Biotechnol 2013, 31:688-91.
49. Nekrasov V, Staskawicz B, Weigel D, Jones JDG, Kamoun S: Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat Biotechnol 2013, 31:691-3.
50. Shan Q, Wang Y, Li J, Zhang Y, Chen K, Liang Z, Zhang K, Liu J, Xi JJ, Qiu J, Gao C: Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol 2013, 31:686-8.
51. Xie K, Yang Y: RNA-Guided Genome Editing in Plants Using a CRISPR-Cas System. Mol Plant 2013, 6:1975-83.
52. Miao J, Guo D, Zhang J, Huang Q, Qin G, Zhang X, Wan J, Gu H, Qu L: Targeted mutagenesis in rice using CRISPR-Cas system. Cell Res 2013, 23:1233-6.
53. Jiang W, Zhou H, Bi H, Fromm M, Yang B, Weeks DP: Demonstration of CRISPR/Cas9/sgRNA-mediated targeted gene modification in Arabidopsis, tobacco, sorghum and rice. Nucleic Acids Res 2013, 41:e188.
54. Upadhyay SK, Kumar J, Alok A, Tuli R: RNA Guided Genome Editing for Target Gene Mutations in Wheat. G3 (Bethesda) 2013.
55. Nakayama T, Fish MB, Fisher M, Oomen-Hajagos J, Thomsen GH, Grainger RM: Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis. Genesis 2013.
56. Tan W, Carlson DF, Lancto CA, Garbe JR, Webster DA, Hackett PB, Fahrenkrug SC: Efficient nonmeiotic allele introgression in livestock using custom endonucleases. Proc Natl Acad Sci USA 2013, 110:16526-31.
57. Li D, Qiu Z, Shao Y, Chen Y, Guan Y, Liu M, Li Y, Gao N, Wang L, Lu X, Zhao Y, Liu M: Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol 2013, 31:681-3.
58. Li W, Teng F, Li T, Zhou Q: Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol 2013, 31:684-6.
59. Shen B, Zhang J, Wu H, Wang J, Ma K, Li Z, Zhang X, Zhang P, Huang X: Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. Cell Res 2013, 23:720-3.
60. Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R: One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 2013, 153:910-8.
61. Fujii W, Kawasaki K, Sugiura K, Naito K: Efficient generation of large-scale genome-modified mice using gRNA and CAS9 endonuclease. Nucleic Acids Res 2013, 41:e187.
62. Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A: Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 1987, 169:5429-33.
63. Bolotin A, Quinquis B, Sorokin A, Ehrlich SD: Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (Reading, Engl) 2005, 151:2551-61.
64. Mojica FJM, Díez-Villaseñor C, García-Martínez J, Soria E: Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 2005, 60:174-82.
65. Pourcel C, Salvignol G, Vergnaud G: CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology (Reading, Engl) 2005, 151:653-63.
66. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P: CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007, 315:1709-12.
67. Wiedenheft B: In defense of phage: viral suppressors of CRISPR-mediated adaptive immunity in bacteria. RNA Biol 2013, 10:886-90.
68. Deveau H, Barrangou R, Garneau JE, Labonté J, Fremaux C, Boyaval P, Romero DA, Horvath P, Moineau S: Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 2008, 190:1390-400.
69. Horvath P, Romero DA, Coûté-Monvoisin A, Richards M, Deveau H, Moineau S, Boyaval P, Fremaux C, Barrangou R: Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J Bacteriol 2008, 190:1401-12.
70. Paez-Espino D, Morovic W, Sun CL, Thomas BC, Ueda K, Stahl B, Barrangou R, Banfield JF: Strong bias in the bacterial CRISPR elements that confer immunity to phage. Nat Commun 2013, 4:1430.
71. Swarts DC, Mosterd C, van Passel MWJ, Brouns SJJ: CRISPR interference directs strand specific spacer acquisition. PLoS ONE 2012, 7:e35888.
72. Yosef I, Goren MG, Qimron U: Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res 2012, 40:5569-76.
73. Datsenko KA, Pougach K, Tikhonov A, Wanner BL, Severinov K, Semenova E: Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun 2012, 3:945.
74. Brouns SJJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJH, Snijders APL, Dickman MJ, Makarova KS, Koonin EV, van der Oost J: Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008, 321:960-4.
75. Carte J, Wang R, Li H, Terns RM, Terns MP: Cas6 is an endoribo-nuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev 2008, 22:3489-96.
76. Gesner EM, Schellenberg MJ, Garside EL, George MM, Macmillan AM: Recognition and maturation of effector RNAs in a CRISPR interference pathway. Nat Struct Mol Biol 2011, 18:688-92.
77. Haurwitz RE, Jinek M, Wiedenheft B, Zhou K, Doudna JA: Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 2010, 329:1355-8.
78. Haurwitz RE, Sternberg SH, Doudna JA: Csy4 relies on an unusual catalytic dyad to position and cleave CRISPR RNA. EMBO J 2012, 31:2824-32.
79. Sashital DG, Jinek M, Doudna JA: An RNA-induced conformational change required for CRISPR RNA cleavage by the endoribonuclease Cse3. Nat Struct Mol Biol 2011, 18:680-7.
80. Hale CR, Majumdar S, Elmore J, Pfister N, Compton M, Olson S, Resch AM, Glover CVC, Graveley BR, Terns RM, Terns MP: Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. Mol Cell 2012, 45:292-302.
81. Hale CR, Zhao P, Olson S, Duff MO, Graveley BR, Wells L, Terns RM, Terns MP: RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 2009, 139:945-56.
82. Jore MM, Lundgren M, van Duijn E, Bultema JB, Westra ER, Waghmare SP, Wiedenheft B, Pul U, Wurm R, Wagner R, Beijer MR, Barendregt A, Zhou K, Snijders APL, Dickman MJ, Doudna JA, Boekema EJ, Heck AJR, van der Oost J, Brouns SJJ: Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat Struct Mol Biol 2011, 18:529-36.
83. Lintner NG, Kerou M, Brumfield SK, Graham S, Liu H, Naismith JH, Sdano M, Peng N, She Q, Copié V, Young MJ, White MF, Lawrence CM: Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem 2011, 286:21643-56.
84. Nam KH, Haitjema C, Liu X, Ding F, Wang H, DeLisa MP, Ke A: Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system. Structure 2012, 20:1574-84.
85. Rouillon C, Zhou M, Zhang J, Politis A, Beilsten-Edmands V, Cannone G, Graham S, Robinson CV, Spagnolo L, White MF: Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol Cell 2013, 52:124-34.
86. Spilman M, Cocozaki A, Hale C, Shao Y, Ramia N, Terns R, Terns M, Li H, Stagg S: Structure of an RNA silencing complex of the CRISPR-Cas immune system. Mol Cell 2013, 52:146-52.
87. Wiedenheft B, Lander GC, Zhou K, Jore MM, Brouns SJJ, van der Oost J, Doudna JA, Nogales E: Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature 2011, 477:486-9.
88. Wiedenheft B, van Duijn E, Bultema JB, Bultema J, Waghmare SP, Waghmare S, Zhou K, Barendregt A, Westphal W, Heck AJR, Heck A, Boekema EJ, Boekema E, Dickman MJ, Dickman M, Doudna JA: RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci USA 2011, 108:10092-7.
89. Reeks J, Naismith JH, White MF: CRISPR interference: a structural perspective. Biochem J 2013, 453:155-66.
90. Zhang J, Rouillon C, Kerou M, Reeks J, Brugger K, Graham S, Reimann J, Cannone G, Liu H, Albers S, Naismith JH, Spagnolo L, White MF: Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell 2012, 45:303-13.
91. Garneau JE, Dupuis M, Villion M, Romero DA, Barrangou R, Boyaval P, Fremaux C, Horvath P, Magadán AH, Moineau S: The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010, 468:67-71.
92. Mulepati S, Bailey S: In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target. J Biol Chem 2013, 288:22184-92.
93. Sinkunas T, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V: Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J 2011, 30:1335-42.
94. Sinkunas T, Gasiunas G, Waghmare SP, Dickman MJ, Barrangou R, Horvath P, Siksnys V: In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J 2013, 32:385-94.
95. Westra ER, van Erp PBG, Künne T, Wong SP, Staals RHJ, Seegers CLC, Bollen S, Jore MM, Semenova E, Severinov K, de Vos WM, Dame RT, de Vries R, Brouns SJJ, van der Oost J: CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell 2012, 46:595-605.
96. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E: A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012, 337:816-21.
97. Kelly TJ, Smith HO: A restriction enzyme from Hemophilus influenzae. II. J Mol Biol 1970, 51:393-409.
98. Smith HO, Wilcox KW: A restriction enzyme from Hemophilus influenzae. I. Purification and general properties. J Mol Biol 1970, 51:379-91.
99. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E: CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 2011, 471:602-7.
100. Gasiunas G, Barrangou R, Horvath P, Siksnys V: Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA 2012, 109:E2579-86.
101. Lieber MR, Gu J, Lu H, Shimazaki N, Tsai AG: Nonhomologous DNA end joining (NHEJ) and chromosomal translocations in humans. Subcell Biochem 2010, 50:279-96.
102. Heyer W, Ehmsen KT, Liu J: Regulation of homologous recombination in eukaryotes. Annu Rev Genet 2010, 44:113-39.
103. Pauwels K, Podevin N, Breyer D, Carroll D, Herman P: Engineering nucleases for gene targeting: safety and regulatory considerations. N Biotechnol 2013.
104. Perez-Pinera P, Ousterout DG, Gersbach CA: Advances in targeted genome editing. Curr Opin Chem Biol 2012, 16:268-77.
105. Qi L, Haurwitz RE, Shao W, Doudna JA, Arkin AP: RNA processing enables predictable programming of gene expression. Nat Biotechnol 2012, 30:1002-6.
106. Hutin S, Lee Y, Glaunsinger BA: An RNA element in human interleukin 6 confers escape from degradation by the gammaherpesvirus SOX protein. J Virol 2013, 87:4672-82.
107. Lee HY, Haurwitz RE, Apffel A, Zhou K, Smart B, Wenger CD, Laderman S, Bruhn L, Doudna JA: RNA-protein analysis using a conditional CRISPR nuclease. Proc Natl Acad Sci USA 2013, 110:5416-21.
108. Salvail-Lacoste A, Di Tomasso G, Piette BL, Legault P: Affinity purification of T7 RNA transcripts with homogeneous ends using ARiBo and CRISPR tags. RNA 2013, 19:1003-14.
109. Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR: Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 2013, 493:429-32.